KSKsawery SzlęZak

Ksawery SzlęZak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ksawery SzlęZak has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    APPENDICITIS IN NEONATES (≤28 DAYS OF LIFE): CLINICAL PRESENTATION AND DIAGNOSIS

    by Anna Dominiczak, Katarzyna Mazurek, Marta BrzęCka, Stanisław Rogiński, Miłosz Rogiński, Krzysztof Rogiński, Marek Wojciechowicz, Łukasz Chojnowski, Karolina Kryca, Ksawery SzlęZak

    Neonatal appendicitis is an exceptionally rare condition associated with high morbidity and mortality, primarily due to delayed diagnosis and a nonspecific clinical presentation that overlaps with more common neonatal disorders. The aim of the study: This study aimed to systematically review recently reported cases of neonatal appendicitis with a focus on clinical presentation and diagnostic features. Materials and methods: A systematic review was conducted in accordance with PRISMA guidelines using PubMed and Google Scholar. Fifteen case reports met the inclusion criteria. Results: Abdominal distension was the most frequently reported presenting symptom. Classic signs of acute abdomen were often absent. Laboratory findings were nonspecific and preoperative diagnosis was uncommon. Ultrasonography provided supportive diagnostic information, while pneumoperitoneum on plain radiography often prompted urgent surgical intervention. In most cases, the diagnosis was established intraoperatively, frequently after appendiceal perforation. Conclusions: Neonatal appendicitis presents with nonspecific clinical and diagnostic features that commonly mimic necrotizing enterocolitis. Awareness of abdominal distension as a consistent sign and careful interpretation of imaging findings may support earlier recognition and timely surgical management of this rare but life-threatening condition.

  • Open Access

    LUNG ULTRASOUND IN THE DIAGNOSIS OF MECONIUM ASPIRATION SYNDROME IN NEONATES: A SYSTEMATIC REVIEW

    by Katarzyna Mazurek, Marek Wojciechowicz, Marta BrzęCka, Stanisław Rogiński, Łukasz Chojnowski, Anna Dominiczak, Krzysztof Rogiński, Ksawery SzlęZak, Karolina Kryca, Karolina Rogińska

    The aim of the study: Meconium aspiration syndrome (MAS) remains an important cause of neonatal respiratory distress and is traditionally diagnosed using clinical criteria supported by chest X-ray. Lung ultrasound (LUS) is a radiation-free, bedside imaging modality increasingly used in neonatal lung diseases. The objective of this systematic review is to evaluate the diagnostic role of LUS in neonates with MAS. Materials and methods: A systematic literature search was conducted in PubMed and Google Scholar in accordance with the PRISMA 2020 guidelines. Original studies involving neonates with MAS and reporting MAS-specific LUS data were included. Studies were excluded if they were non-English, animal studies, lacked original data, involved non-MAS populations or focused on therapy guidance rather than diagnosis. Results: Five studies met the inclusion criteria. Across the included studies, LUS demonstrated high diagnostic performance for MAS, with reported sensitivity ranging from 90% to 100% and specificity 99.3% to 100%. Characteristic LUS findings included lung consolidations with air bronchogram, pleural line abnormalities, disappearance of A-lines and alveolar-interstitial syndrome. Conclusions: LUS appears to be a reliable diagnostic tool for MAS and offers important advantages including absence of ionizing radiation and bedside applicability. It may be considered a first-line imaging modality in infants with suspected MAS, with chest X-ray reserved for cases of diagnostic uncertainty. Further studies are needed to confirm these findings.

  • Open Access

    CURRENT PREVENTION STRATEGIES FOR INFLUENZA VIRUS INFECTION: EVIDENCE, PRACTICE, AND THE ROLE OF MATERNAL VACCINATION

    by Ksawery Szlęzak, Zuzanna Tomaszewska, Anna Zielińska, Anna Sobczak

    Background: Seasonal influenza remains a major cause of morbidity and mortality in Europe. Prevention relies primarily on vaccination, supported by non-pharmaceutical interventions (NPIs) and surveillance. Pregnant women are a key target group, as maternal immunization protects both mother and infant. Methodology: A narrative review of recent PubMed-indexed studies, complemented by European Centre for Disease Prevention and Control (ECDC) reports and national data from Poland, was undertaken. Evidence on vaccine effectiveness, safety of maternal immunization, vaccination coverage, and the role of NPIs was synthesized. Results: Influenza vaccine effectiveness in Europe has been moderate, ranging from 32–55% depending on subtype and season, with highest protection against influenza B and lowest against A(H3N2). Maternal vaccination provides significant protection for infants under six months, particularly when administered in the third trimester, and shows no association with adverse pregnancy outcomes. Despite strong evidence, vaccine uptake in Poland remains among the lowest in Europe, with only about 10% coverage in older adults and minimal uptake among pregnant women. NPIs, including mask use and hand hygiene, reduce transmission and are particularly valuable in seasons of poor vaccine match. Discussion: Vaccination is the cornerstone of influenza prevention, yet insufficient coverage undermines its impact. Maternal immunization remains underutilized, while NPIs provide important complementary protection. Barriers include cost, misinformation, and logistical challenges. Conclusions: Effective influenza prevention requires higher vaccine uptake, integration of maternal immunization into routine prenatal care, selective use of NPIs, and stronger surveillance. Without systemic improvements, the potential of influenza prevention cannot be fully realized.

  • Open Access

    Wewnątrznaczyniowe leczenie zwężeń tętnic przeszczepionej allogenicznej nerki

    by Jakub Szczerbiński, Ksawery Szlęzak, Krzysztof Bojakowski, Piotr Andziak

    Recent studies have questioned the effectiveness of surgical treatment of renal artery stenosis. However, patients with artery stenosis of the solitary kidney may benefit most from endovascular therapy. Transplant renal artery stenosis is a cause of organ function deterioration, potentially leading to graft loss and increased mortality in the group of patients affected by this complication. However, we do not have data on the optimal treatment of transplant renal artery stenosis. Therapeutic methods includes conservative treatment and possible qualification for surgical treatment. Performing endovascular intervention offers the chance to correct the stenosis and return proper function to the transplanted kidney. Various methods are used during surgery: angioplasty, and stent implantation, including devices that release local antiproliferative drugs. At present, a timely intervention appears to offer the same chances of long-term graft function and survival as in kidney transplant recipients who do not develop TRAS. Data on epidemiology, risk factors and treatment outcomes are sparse, and further studies are needed. Ostatnie badania kwestionują skuteczność chirurgicznego leczenia zwężenia tętnicy nerkowej. Jednak pacjenci ze zwężeniem tętnicy jedynej nerki mogą odnieść największe korzyści z leczenia wewnątrznaczyniowego. Zwężenie tętnicy nerki przeszczepionej jest przyczyną pogorszenia funkcji narządu, potencjalnie mogącą prowadzić do utraty przeszczepu i zwiększenia śmiertelności w grupie chorych dotkniętych tym powikłaniem. Nie dysponujemy jednak danymi dotyczącymi optymalnego leczenia zwężenia tętnicy nerki przeszczepionej. Obejmuje ono leczenie zachowawcze i ewentualną kwalifikację do leczenia zabiegowego. Przeprowadzenie interwencji wewnątrznaczyniowej daje szansę na korekcję zwężenia i powrót właściwej funkcji nerki przeszczepionej. Podczas operacji wykorzystywane są różne metody - angioplastyka, implantacja stentów, w tym również urządzenia uwalniające miejscowo leki antyproliferacyjne. Obecnie wydaje się, że przeprowadzona w porę interwencja daje takie same szanse na długotrwałe funkcjonowanie przeszczepu i przeżycie, jak w grupie biorców przeszczepu nerki nie rozwijających TRAS. Dane dotyczące epidemiologii, czynników ryzyka i wyników leczenia są skąpe, dlatego potrzebne jest przeprowadzenie dalszych badań.